Last updated on May 2020

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

Brief description of study

A 12 month study to measure the efficacy and safety of abaloparatide in men with osteoporosis.

Detailed Study Description

The primary objective of this prospective controlled study is to evaluate the efficacy and the safety of abaloparatide-SC 80 mcg per day compared to placebo as assessed by change in bone mineral density over 12 months.

Clinical Study Identifier: NCT03512262

Find a site near you

Start Over

Radius Health, Inc.

Waltham, MA United States
  Connect »

Alta California Medical Group

Simi Valley, CA United States
  Connect »

Diablo Clinical Research, Inc.

Walnut Creek, CA United States
  Connect »

Meridian Clinical Research

Savannah, GA United States
  Connect »

Northwestern University

Chicago, IL United States
  Connect »

The University of Chicago

Chicago, IL United States
  Connect »

PMG Research of Wilmington, LLC

Wilmington, NC United States
  Connect »

Centex Studies, Inc.

Houston, TX United States
  Connect »

Centex Studies, Inc

McAllen, TX United States
  Connect »

ETG Siedlce

Siedlce, Poland
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.